Showing results (1-10 of 157) with videos related to
Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2012
A focus on PD-L1 in human melanomaPeter Hersey, Stuart GallagherJournal of Surgical Oncology|December 5, 2013
Intralesional immunotherapy for melanomaPeter Hersey, Stuart GallagherAdvances in Pharmacology (San Diego, Calif.)|September 11, 2012
Histone deacetylases (HDACs) as mediators of resistance to apoptosis in melanoma and as targets for combination therapy with selective BRAF inhibitorsFritz Lai, Lei Jin, Stuart Gallagher, et al.Melanoma Management|September 8, 2018
How anti-PD1 treatments are changing the management of melanomaPeter Hersey, Hojabr Kakavand, James Wilmott, et al.Pigment Cell & Melanoma Research|May 10, 2024
BET inhibition sensitizes innate checkpoint inhibitor resistant melanoma to anti-CTLA-4 treatmentHsin-Yi Tseng, Sara Alavi, Stuart Gallagher, et al.Expert Opinion on Investigational Drugs|January 5, 2002
Advances in the non-surgical treatment of melanomaPeter HerseyCurrent Opinion in Oncology|February 8, 2006
Apoptosis and melanoma: how new insights are effecting the development of new therapies for melanomaPeter HerseyPigment Cell & Melanoma Research|February 7, 2020
Do innate killing mechanisms activated by inflammasomes have a role in treating melanoma?Abdullah Al Emran, Hsin-Yi Tseng, Mikaela C Coleman, et al.British Journal of Nursing (Mark Allen Publishing)|February 24, 2017
Developing an e-learning resource for nurse airway assistants in the emergency departmentPeter Hersey, Sean McAleerPageof 16